14Apr
M&A Litigation Rising Amidst COVID-19 Uncertainty: Considerations for Litigators and Deal-Makers
Just as no human being is naturally immune to the COVID-19 virus, no industry is immune to its economic effects—and related M&A activity across all industries proves no exception. In the weeks following the issuance of stay-at-home orders in states...
By:
White and Williams LLP
Related
In today’s edition of Daily Compliance News: China says HSBC set ‘trap’ for Huawei. (WSJ) Lay-of...
Read More >
As novel coronavirus has spread from China to Europe, the United States and around the globe, it has...
Read More >
A recent decision in Sotera Defense Solutions, Inc. v. Department of Agriculture, CBCA 6029, 6030, b...
Read More >
The French Foreign Investments Control regime has recently been reinforced following a reform of 201...
Read More >
Buying a competitor isn’t the only way to bring the attention of federal antitrust agencies. Our An...
Read More >
Employers began to rethink how they obtain authorization and retrieve background and credit checks f...
Read More >